Law groups, professors lash out against Thermo Fisher in suit over the 'immortal cells' of Henrietta Lacks

Nicole DeFeudis

Editor

It’s been decades since medical researchers at Johns Hopkins unethically took tissue samples from Henrietta Lacks and used them to create the world’s first known …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Law groups, professors lash out against Thermo Fisher in suit over the 'immortal cells' of Henrietta Lacks

Nicole DeFeudis

Editor

Sign up to read this article for free.

Applied Therapeutics' rare disease drug gets a CRL

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role

Law groups, pro­fes­sors lash out against Ther­mo Fish­er in suit over the 'im­mor­tal cell­s' of Hen­ri­et­ta Lacks

Nicole DeFeudis

Editor

Sign up to read this article for free.

more like this

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Law groups, professors lash out against Thermo Fisher in suit over the 'immortal cells' of Henrietta Lacks

Applied Therapeutics' rare disease drug gets a CRL

Updated: Amgen obesity shot shows 20% weight loss, but dosing questions hang over readout

To lead NIH, Trump taps Stanford academic and pandemic response critic Jay Bhattacharya

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

Trump team asked Warp Speed leader to head NIH, may seek more traditional pick for role